Point72 Asset Management
NVO

Point72 Asset Management’s Novo Nordisk NVO Stock Holding History

Point72 Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.65M Sell
181,000
-106,500
-37% -$5.05M 0.01% 1505
2025
Q4 		$14.6M Buy
287,500
+98,100
+52% +$5.02M 0.02% 1106
2025
Q3 		$10.5M Sell
189,400
-998,700
-84% -$58.5M 0.02% 778
2025
Q2 		$82M Buy
1,188,100
+1,034,500
+674% +$70.4M 0.16% 148
2025
Q1 		$10.7M Sell
153,600
-43,400
-22% -$3.58M 0.02% 659
2024
Q4 		$16.9M Buy
197,000
+49,600
+34% +$5.36M 0.04% 513
2024
Q3 		$17.6M Buy
147,400
+130,800
+788% +$17.4M 0.04% 461
2024
Q2 		$2.37M Sell
16,600
-100,000
-86% -$13.3M 0.01% 1049
2024
Q1 		$15M Buy
116,600
+16,600
+17% +$1.98M 0.04% 560
2023
Q4 		$10.3M Buy
+100,000
New +$9.89M 0.03% 670

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Point72 Asset Management's NVO Position: Q3 2024 in Review

Point72 Asset Management sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 960,854 shares — an estimated $128M sold.

Point72 Asset Management first reported a position in NVO in Q4 2014 and held it in 10 quarters. The position peaked at $137M in Q2 2024. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Point72 Asset Management reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • Point72 Asset Management sold 960,854 Novo Nordisk shares in Q3 2024, an estimated $128M.
  • Point72 Asset Management first reported a position in Novo Nordisk in Q4 2014 and held it in 10 quarters.
  • Point72 Asset Management's Novo Nordisk position peaked at $137M in Q2 2024.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Point72 Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.